CRS: BJMC
Position: Community Coordinator
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
